Instrument-assisted Soft Tissue Mobilization Versus Integrated on Mechanical Neck Pain (IASTM)

June 22, 2022 updated by: Al Shaymaa Shaaban Abd El Azeim, Cairo University

Instrument-assisted Soft Tissue Mobilization Versus Integrated Neuromuscular Inhibition Technique on Mechanical Non-specific Neck Pain

the aim of this study is to investigate the efficacy of instrumented assisted soft tissue mobilization versus integrated neuromuscular inhibition technique on mechanical non-specific neck pain

Study Overview

Detailed Description

Mechanical neck pain is a prevalent condition in various populations. Neck pain occurrence is affected by several factors, involving environmental, psychological, and social aspects. Neck pain represents the fourth major disorder responsible for a person's year lived with disability and ranked eleventh as disability-adjusted life years of a person. The neck pain incidence ranges from 10.4 to 23.3% in 1-year time, while the range of prevalence was 0.4 to 86.8%. It has a high prevalence among computer users, office workers, and females, especially females aged 35 to 49 years old. Myofascial trigger point (MTrP) might play an important role in the formation of mechanical neck pain and is known as a hyperirritable spot in skeletal muscle that is accompanied with a hypersensitive palpable nodule in a taut band. IASTM and integrated play an important role in the treatment of mechanical neck pain.this trial has three groups; one will receive IASTM+ conventional, the second will receive integrated + conventional and the third will receive conventional treatment for four week

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt, 12511
        • Al Shaymaa Shaaban Abd El Azeim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. diagnosed as non-specific neck pain with upper trapezius active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern
  2. body mass index from 18 to 25 kg/m2
  3. their ages from 18-35

Exclusion Criteria:

  1. if they had trigger point injections within the past 6 months
  2. history of neck or upper back surgery, trauma or fracture
  3. history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities
  4. cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: instrument assisted soft tissue mobilization
the patients will receive instrument-assisted soft tissue mobilization+conventional therapy three times per week for four week
the patients will receive instrument-assisted soft tissue mobilization:The subject was seated in a relaxed sitting position. M2T blade was used to find specific areas of restriction on RT upper trapezius. Then treatment plane 1 - 2 and 3 were used.The lubricant (Vaseline) was applied to the skin around the neck area prior to treatment and the tool was cleaned with an alcohol preparation pad. Then by using M2T blade with angle 45, we were giving long slow strokes without causing any discomfort or pain over muscle starting from its insertion up to its origin approximately for 2 to 3 min repeated two times.
the patients will receive hot back for 10 minutes, active range of motion exercise, chin tuck, stretches
EXPERIMENTAL: integrated neuromuscular inhibition technique
the patients will receive integrated neuromuscular inhibition technique+ conventional therapy. three times a week for four week
the patients will receive hot back for 10 minutes, active range of motion exercise, chin tuck, stretches
will receive integrated neuromuscular inhibition technique: from supine lying position.we the patients will perform ischemic compression at trigger points then positional release technique and finally muscle energy technique.
ACTIVE_COMPARATOR: conventional therapy
the patients will receive conventional therapy three times a week for four week
the patients will receive hot back for 10 minutes, active range of motion exercise, chin tuck, stretches

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: up to four weeks
The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain
up to four weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neck disability
Time Frame: up to four weeks
will be measured by Arabic neck disability index
up to four weeks
muscle amplitude in the form of normalized root mean square (RMS)
Time Frame: up to four weeks
muscle amplitude will be measured by surface electromyography for upper trapezius
up to four weeks
muscle fatigue in the form of median frequency
Time Frame: up to four weeks
muscle fatigue will be measured by surface electromyography for upper trapezius
up to four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2021

Primary Completion (ACTUAL)

March 30, 2021

Study Completion (ACTUAL)

March 30, 2021

Study Registration Dates

First Submitted

January 6, 2021

First Submitted That Met QC Criteria

January 7, 2021

First Posted (ACTUAL)

January 8, 2021

Study Record Updates

Last Update Posted (ACTUAL)

June 23, 2022

Last Update Submitted That Met QC Criteria

June 22, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • p.t.REC/012/003038

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-specific Chronic Mechanical Neck Pain

Clinical Trials on instrument assisted soft tissue mobilization

3
Subscribe